Status:
WITHDRAWN
A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco
Lead Sponsor:
Pfizer
Conditions:
COVID-19 Drug Treatment
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect information on the: * general information of a group of people such as their age, sex, and other facts. * clinical information of the patients such as any othe...
Eligibility Criteria
Inclusion
- Confirmed COVID-19 infection during the study period from 01 June 2022 to 30 June 2023
- Nirmatrelvir, ritonavir written prescription
Exclusion
- There are no exclusion criteria for this study.
Key Trial Info
Start Date :
March 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05997485
Start Date
March 30 2024
End Date
June 30 2024
Last Update
March 28 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.